Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Human Psychopharmacology|April 26, 2021
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging studyStephen J Kish, Gerald O'Leary, Mortimer Mamelak, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 12, 2020
Towards safer risperidone prescribing in Alzheimer's diseaseSuzanne Reeves, Julie Bertrand, Hiroyuki Uchida, et al.
Therapeutic Advances in Psychopharmacology|May 28, 2021
Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic studyNobuyuki Nomura, Kohei Kitagawa, Ryuhei So, et al.
Journal of Clinical Pharmacology|February 17, 2026
Mechanism-Based Predictions of Local Tissue and Systemic Exposure for Drug Products Delivered Through the Female Reproductive TractXinnong Li, Thomas Straubinger, Lisa C Rohan, et al.
Journal of Clinical Psychopharmacology|December 8, 2021
Clozapine Once-Daily Versus Divided Dosing Regimen: A Cross-sectional Study in JapanKohei Kitagawa, Ryuhei So, Nobuyuki Nomura, et al.
Dialogues in Clinical Neuroscience|January 28, 2009
Incomplete response in late-life depression: getting to remissionEric J Lenze, Meera Sheffrin, Henry C Driscoll, et al.
British Journal of Clinical Pharmacology|February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patientsMohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
JNCI Cancer Spectrum|May 2, 2024
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancerPatrick M Boland, John M L Ebos, Kristopher Attwood, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate CancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Pageof 5